{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/724-US10,975,364(Active) re (Done on website already).pdf"}, "page_content": "28\n\n<211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Synthesized\n\n<400> SEQUENCE: 174\n\nagctctccaa ggagaageca aaaaate\n\n27\n\nSEQ <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Synthesized\n\n<400> SEQUENCE: 175\n\n27\n\nggctccccca ggagatgacc agatagt\n\nSEQ <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Synthesized\n\n<400> SEQUENCE: 176\n\n27\n\nagttctccaa ggagaagace acgtggt\n\nSEQ <211> LENGTH: 28 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Synthesized\n\n<400> SEQUENCE: 177\n\n28\n\ngcgcccactg caaggcccgg egeacggt\n\n<210> SEQ ID NO 178 <211> LENGTH: 28 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Synthesized\n\nSynthesized\n\nSynthesized\n\n<210>\n\nSEQ\n\nID\n\nNO\n\n174\n\n<210>\n\nID\n\nNO\n\n175\n\n<210>\n\nID\n\nNO\n\n176\n\n<210>\n\nID\n\nNO\n\n177\n\nUS 10.975,364 B2\n\n92\n\n91\n\ncontinued\n\n< 400 > SEQUENCE : 178\n\naggcccactg caaggcccag tgggcggc\n\n28\n\n< 210 > SEQ ID NO 179\n\n< 211 > LENGTH : 28\n\n< 212 > TYPE : DNA\n\n< 213 > ORGANISM : Artificial Sequence\n\n< 220 > FEATURE :\n\n< 223 > OTHER INFORMATION : Synthesized\n\n< 400 > SEQUENCE : 179\n\ngcgcccactg cagggcccgg ctgcggag\n\n28\n\n< 210 > SEQ ID NO 180\n\n< 211 > LENGTH : 27\n\n< 212 > TYPE : DNA\n\n< 213 > ORGANISM : Artificial Sequence\n\n< 220 > FEATURE :\n\n< 223 > OTHER INFORMATION : Synthesized\n\n< 400 > SEQUENCE : 180\n\nggggtcccag gtgctgacgt aggtagt\n\n27\n\nsequence , an affinity tag or a fusion base editor protein ,\n\nThe invention claimed is :\n\n1. A modified Streptococcus aureus Cas9 protein with a\n\nwherein the modified protein comprises the amino acid\n\nmutation at an N413 position , and optionally one or more of 30 sequence selected from SEQ ID NO : 1 , SEQ ID NO : 2 , SEQ\n\na nuclear localization sequence , a cell penetrating peptide\n\nID NO : 3 , SEQ ID NO : 4 or a homologue thereof having at", "type": "Document"}}